跳至主要内容
临床试验/CTRI/2023/12/060745
CTRI/2023/12/060745尚未招募3 期

A Randomized Double Blind Placebo Controlled trial Evaluating the Efficacy of Alpha Lipoic Acid as Add-On Therapy on Cognitive Impairment in Schizophrenia Patients of a Tertiary Care Hospital - nil

Dr Ramya R0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Schizophrenia diagnosis made by research psychiatrists using the Structured Clinical Interview, SCID-5, for Diagnostic and Statistical Manual of Mental Disorders of more than 2 years duration and on treatment
  • 2)Cognitive symptoms despite adequate antipsychotic treatment assessed by MOCA scored < 26
  • 3)Age 18-60 years of either gender
  • 4)Willing to participate

排除标准

  • 1)6-months history of any drug or alcohol abuse or dependence
  • 2)Changes in psychotropic medications within the last 4 weeks and patients on valproate use (potential interaction with ALA)
  • 3)Women who are planning to become pregnant, are pregnant, or are breastfeeding
  • 4)Known chronic infections such as HIV or hepatitis C, and liver or renal failure that could adversely impact on patient outcome

研究者

发起方
Dr Ramya R

相似试验

A study of the effect of Alpha lipoic acid in... | 临床试验